CD81 Antibody - BSA Free

Western Blot: CD81 Antibody [NBP2-20564] -

Western Blot: CD81 Antibody [NBP2-20564] - Various whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with CD81 antibody (NBP2-20564) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.

Flow Cytometry: CD81 Antibody [NBP2-20564] -

CD81 antibody (NBP2-20564) detects CD81 by flow cytometry analysis.
Sample: THP-1 cell.
Black: Unlabelled sample was used as a control.
Red: CD81 antibody (NBP2-20564) dilution: 1:50.
Acquisition of 20,000 events were collected for FACS analysis.

Western Blot: CD81 Antibody - BSA Free [NBP2-20564] -

Decreased expression levels of eGPC3 in patients with gastro-esophageal adenocarcinomas (GEA). (A) Nanoparticle tracking analysis (NTA) diagram of nanoparticle concentration and average particle size from serum samples of patients with GEA (n = 9; blue line), healthy donors (n = 9; red line) and patients with non-malignant disease (n = 9; green line). (B) Transmission electron microscopy (TEM) images of serum derived vesicles (black arrowheads). (C) Quantification of exosome-associated proteins CD9, CD63 and TSG101 determined by fluorescent NTA (p < 0.05, two-paired student´s t-test). (D) Protein expression analyses of exosome-derived GPC3, TSG101, CD81, CD63, and CD9. Calreticulin was used as a marker for cytoplasm-derived contamination (bottom panel). Representative quantification of GPC3 levels of serum-derived exosomes from patients with GEA compared to serum-derived exosomes from healthy donors and patients with non-malignant disease (right panel, p < 0.05 two-paired student´s t-test). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31100935), licensed under a CC-BY license. Not internally tested by Novus Biologicals.